Repligen | RGEN - 普通股股本



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.27B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


普通股股本 更改 日
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 1000 2026-06
Bio Techne USD 156.45M 703K 2026-03
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Bruker USD 152.35M 130K 2026-06
Charles River Laboratories USD 47.73M 439K 2026-06
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
General Electric Aerospace USD 1.04B 5.77M 2026-06
Henry Schein USD 111.92M 2.51M 2026-06
Illumina USD 151.3M 607K 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Pfizer USD 5.7B 0 2026-06
Repligen USD 56.43M 28K 2026-06
Revvity USD 111.63M 174K 2026-06
Standard Biotools USD 390.14M 3.76M 2026-03
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Waters USD 98.19M 20K 2026-06
West Pharmaceutical Services USD 70.4M 500K 2026-06